No results found.

Screeners (33,980)

Signal Glossary

DTL Breach Warning
Price has pushed through the Demand Threshold Line (those orange bars). It flags price vulnerability at/through that boundary for the current week.
Smart Money Buy
A โ€œsmart moneyโ€ star printed on the chart. It marks concentrated, high-quality buying activity often seen ahead of stronger moves. (We only log it when the star appears.)
Investor Buy
An โ€œinvestor buyโ€ star printed on the chart. It reflects broader, more general momentum by investors. (Again, only logged when the star appears.)
Accumulation
A green bar (often within a negative market cycle). Each green bar signals steady, systematic buying/absorbing of supply.
Distribution
The counterpart to accumulation. It marks persistent selling/handing off of shares - supply is dominating and pressure is to the downside.
Ribbon Change
The ribbon flips color (red โ†” green). We log the first bar of a new segment, which signals a regime shift in the underlying indicator.
Threshold Breach (Buy)
The composite indicator crosses down through the dynamic Bottom threshold. Itโ€™s a โ€œbuy-sideโ€ extreme that often precedes an upward move.
Threshold Breach (Sell)
The composite indicator crosses up through the dynamic Top threshold. Itโ€™s a โ€œsell-sideโ€ extreme that often precedes a downward move.
Baseline Crossover
The tracked metric crosses its baseline (typically zero). Crossing up suggests improving conditions; crossing down suggests deterioration.
Demand โˆ’1 Crossover
Price crosses up through the โ€œโˆ’1 demandโ€ reference level. It signals a possible early improvement in demand conditions after a weak phase.
Valuation Change
A change in our valuation classification (e.g., from overvalued to fairly valued). It captures a material update to the valuation state for screening.
Info Update
A notable informational event (e.g., earnings/guidance/corporate update) that we tag for the screener so you can filter around fresh developments.
ML Turned Positive
The Magic Line (smoothed activity) crosses above zero and turns positive. It indicates a shift toward constructive momentum/pressure.
ML Turned Negative
The Magic Line crosses below zero and turns negative. It indicates a shift toward weakening momentum/pressure.

Nasdaq

(NASDAQ)
AURA
Aura Biosciences, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BLFY
Blue Foundry Bancorp
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BLZE
Backblaze, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BNZI
Banzai International, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BTMD
biote Corp.
?
Accumulation ?
C1 F1 O1 R1
?
Deeply Undervalued
Target: 3.87 ?
CFLT
Confluent, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CTKB
Cytek Biosciences, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
DH
Definitive Healthcare Corp.
?
Accumulation ?
C1 F1 O3 R1
?
Fairly Valued
Target: 2.94 ?
DIBS
1stdibs.Com, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
GCL
GCL Global Holdings Ltd
?
Accumulation ?
C3 F2 O2 R3
?
Significantly Overvalued
Target: 1.00 ?
GFS
GlobalFoundries Inc.
?
Accumulation ?
C3 F1 O3 R1
?
Deeply Overvalued
Negative ?
JANX
Janux Therapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
PLTK
Playtika Holding Corp.
?
Accumulation ?
C2 F1 O2 R2
?
Extremely Undervalued
Positive ?
RZLV
Rezolve AI PLC
?
Accumulation ?
No valuation data
?
โ€”
โ€”
SNCY
Sun Country Airlines Holdings, Inc.
?
Accumulation ?
C1 O1 R1
?
Extremely Undervalued
Positive ?
AAL
American Airlines Group Inc.
?
Accumulation ?
C1 F1 O1 R1
?
Extremely Undervalued
Positive ?
ACTG
Acacia Research Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
AGMH
AGM Group Holdings Inc.
?
Accumulation ?
C3 F2 R1
?
Significantly Overvalued
Target: 2.17 ?
ALDX
Aldeyra Therapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
ALGT
Allegiant Travel Company
?
Accumulation ?
C1 F1 R1
?
Significantly Overvalued
Target: 48.29 ?
APLS
Apellis Pharmaceuticals, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
APPN
Appian Corporation
?
Accumulation ?
C3 F2 O2 R2
?
Extremely Undervalued
Positive ?
BEEM
Beam Global
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BTAI
BioXcel Therapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CCCC
C4 Therapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CLAR
Clarus Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CMCO
Columbus McKinnon Corporation
?
Accumulation ?
C2 F1 O2 R1
?
Extremely Undervalued
Positive ?
CMRC
Commerce.com, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
COO
The Cooper Companies, Inc.
?
Accumulation ?
C1 F1 O2 R2
?
Significantly Overvalued
Target: 50.97 ?
DNLI
Denali Therapeutics Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
EXPO
Exponent, Inc.
?
Accumulation ?
C3 F2 O3 R2
?
Significantly Overvalued
Target: 42.20 ?
FELE
Franklin Electric Co., Inc.
?
Accumulation ?
C1 F1 O2 R2
?
Moderately Overvalued
Target: 86.60 ?
GNTX
Gentex Corporation
?
Accumulation ?
C2 F1 O3 R2
?
Significantly Undervalued
Target: 29.18 ?
ICFI
ICF International, Inc.
?
Accumulation ?
C1 O2 R2
?
Deeply Undervalued
Positive ?
ICLR
ICON Public Limited Company
?
Accumulation ?
C1 O2 R1
?
Significantly Undervalued
Target: 203.76 ?
JBHT
J.B. Hunt Transport Services, Inc.
?
Accumulation ?
C1 F1 O1 R1
?
Moderately Overvalued
Target: 135.07 ?
JBSS
John B. Sanfilippo & Son, Inc.
?
Accumulation ?
C2 F2 R3
?
Moderately Overvalued
Target: 57.27 ?
LAB
Standard BioTools Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
MATW
Matthews International Corporation
?
Accumulation ?
C2 F1 O2 R1
?
Significantly Overvalued
Target: 14.71 ?
MGPI
MGP Ingredients, Inc.
?
Accumulation ?
C1 O1 R3
?
Moderately Undervalued
Target: 26.87 ?
MRVI
Maravai LifeSciences Holdings, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
MXL
MaxLinear, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
MZTI
The Marzetti Company
?
Accumulation ?
No valuation data
?
โ€”
โ€”
PCVX
Vaxcyte, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
SRDX
Surmodics, Inc.
?
Accumulation ?
C1 O3 R1
?
Extremely Overvalued
Negative ?
TTGT
TechTarget, Inc.
?
Accumulation ?
C3 F2 O2 R2
?
Extremely Undervalued
Positive ?
VALU
Value Line, Inc.
?
Accumulation ?
C2 F1 O3 R2
?
Fairly Valued
Target: 37.66 ?
VCYT
Veracyte, Inc.
?
Accumulation ?
C2 F2 O3 R1
?
Extremely Overvalued
Negative ?
VRDN
Viridian Therapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
XXII
22nd Century Group, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”